1. Home
  2. ACCL vs HOTH Comparison

ACCL vs HOTH Comparison

Compare ACCL & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.40

Market Cap

19.5M

ML Signal

N/A

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
HOTH
Founded
2009
2017
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
15.8M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
ACCL
HOTH
Price
$1.40
$1.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
2.3M
855.2K
Earning Date
03-03-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
2.91
N/A
EPS
0.08
N/A
Revenue
$4,888,824.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.25
N/A
Revenue Growth
11.91
N/A
52 Week Low
$1.23
$0.66
52 Week High
$5.00
$2.12

Technical Indicators

Market Signals
Indicator
ACCL
HOTH
Relative Strength Index (RSI) 29.97 54.55
Support Level $1.35 $0.77
Resistance Level $1.69 $1.06
Average True Range (ATR) 0.13 0.08
MACD 0.05 0.02
Stochastic Oscillator 34.80 84.06

Price Performance

Historical Comparison
ACCL
HOTH

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: